Advertisement

Canadian Journal of Public Health

, Volume 104, Issue 1, pp e9–e11 | Cite as

Reducing the Public Health Risk of Escherichia coli O157 Exposure by Immunization of Cattle

  • Glenn G. Smith
  • Susan E. Goebel
  • Charles R. Culbert
  • Louis A. Guilbault
Commentary

Abstract

The One Health approach investigates the complexities surrounding the interplay between the animal, human and environmental domains. Zoonotic pathogens, such as Escherichia coli (E. coli) O157, which have animal reservoirs, also have direct impact on public health. Cattle are the primary reservoir of E. coli O157, however infection with this bacterium is asymptomatic. Infected cattle appear healthy and have normal growth rates and milk production abilities. Each year, thousands of Canadians become ill following exposure to E. coli O157. To reduce this public health risk, immunization of cattle would be an effective intervention. Several models have shown that on-farm pathogen reduction programs would significantly reduce the risk of human illness.

Key words

E. coli O157 One Health pre-harvest 

Résumé

L’approche «Une seule santé » porte sur l’action réciproque complexe entre les domaines animal, humain et environnemental. Les agents pathogènes zoonotiques comme Escherichia coli (E. coli) O157, qui ont des réservoirs animaux, ont aussi un impact direct sur la santé publique. Les bovins sont le principal réservoir d’E. coli O157, mais l’infection par cette bactérie est asymptomatique. Les bovins infectés semblent en bonne santé et ont des taux de croissance et des capacités de production laitière normaux. Chaque année, des milliers de Canadiens tombent malades après avoir été exposés à E. coli O157. La vaccination des bovins serait une mesure efficace pour réduire ce risque pour la santé publique. Plusieurs modèles ont montré que les programmes de réduction des agents pathogènes dans les élevages réduiraient significativement le risque de maladie chez les humains.

Mots clés

Escherichia coli O157 Une seule santé pré-récolte 

References

  1. 1.
    Culbert R, Wilson J, Papadopoulos A, Goebel S. The One Health challenge of implementing cattle vaccination against E. coli O157 to reduce the risk of human infection: A case study. 1st International One Health Congress, 2011;S99. Available at: http://www.onehealthinitiative.com/publications/OneHealth%20Suppl%20Abstracts.pdf. (Accessed June 4, 2012).Google Scholar
  2. 2.
    Karmali MA, Gannon V, Sargeant JM. Verocytotoxin-producing Escherichia coli (VTEC). Vet Microbiol 2010;40(3-4):360–70.CrossRefGoogle Scholar
  3. 3.
    Clark WF, Macnab JJ, Sontrop JM. The Walkerton Health Study 2002–2008 Final Report. London, ON: London Health Sciences Centre, 2008.Google Scholar
  4. 4.
    Pearl DL, Louie M, Chui L, Doré K, Grimsrud KM, Martin SW, et al. A multilevel approach for investigating socio-economic and agricultural risk factors associated with rates of reported cases of Escherichia coli O157 in humans in Alberta, Canada. Zoonoses Public Health 2009;56(8):455–64.CrossRefGoogle Scholar
  5. 5.
    Withee J, Williams M, Disney T, Schlosser W, Bauer N, Ebel E. Streamlined analysis for evaluating the use of preharvest interventions intended to prevent Escherichia coli O157:H7 illness in humans. Foodborne Pathog Dis 2009;6(7):817–25.CrossRefGoogle Scholar
  6. 6.
    Williams MS, Withee JL, Ebel ED, Bauer NE Jr, Schlosser WD, Disney WT, et al. Determining relationships between the seasonal occurrence of Escherichia coli O157:H7 in live cattle, ground beef, and humans. Foodborne Pathog Dis 2010;7(10):1247–54.CrossRefGoogle Scholar
  7. 7.
    Smith DR, Moxley RA, Peterson RE, Klopfenstein TJ, Erickson GE, Bretschneider G, et al. A two-dose regimen of a vaccine against Escherichia coli O157 type III secreted proteins reduced environmental transmission of the agent in a large-scale commercial beef feedlot clinical trial. Foodborne Pathog Dis 2009;6(2):155–61.CrossRefGoogle Scholar
  8. 8.
    Matthews L, McKendrick IJ, Ternent H, Gunn GJ, Synge B, Woolhouse ME. Super-shedding cattle and the transmission dynamics of Escherichia coli O157. Epidemiol Infect 2006;134(1):131–42.CrossRefGoogle Scholar
  9. 9.
    Cross P, Rigby D, Edwards-Jones G. Eliciting expert opinion on the effectiveness and practicality of interventions in the farm and rural environment to reduce human exposure to Escherichia coli O157. Epidemiol Infect 2012;140(4):643–54.CrossRefGoogle Scholar
  10. 10.
    Smith BA, Fazil A, Lammerding AM. A risk assessment model for Escherichia coli O157:H7 in ground beef and beef cuts in Canada: Evaluating the effects of interventions. Food Control 2012;3:1–18.Google Scholar
  11. 11.
    Ellis-Iversen J, Cook AJ, Watson E, Nielen M, Larkin L, Wooldridge M, et al. Perceptions, circumstances and motivators that influence implementation of zoonotic control programs on cattle farms. Prev Vet Med 2010;93(4):276–85.CrossRefGoogle Scholar
  12. 12.
    Strategic Research Associates, 2010. Available at: http://www.econichevaccine.com/docs/Producer-Survey-2009.pdf (Accessed September 4, 2012).
  13. 13.
    Canadian Association of Bovine Practitioners Activities, 2008. Available at: http://www.cabv.ca/file/Bioniche%20Letter%20of%20Endorsement%20-%20July%2028%2008.pdf (Accessed June 4, 2012).
  14. 14.
    Report of the Standing Committee on Agriculture and Agri-Food. Competitiveness of Canadian Agriculture: Final Report. Ottawa, ON: House of Commons, 2010.Google Scholar
  15. 15.
    United States Department of Agriculture Food Safety Inspection Service, 2010. Available at: http://www.fsis.usda.gov/PDF/Reducing_Ecoli_Shedding_In_Cat-tle_0510.pdf (Accessed July 5 2012).

Copyright information

© The Canadian Public Health Association 2012

Authors and Affiliations

  • Glenn G. Smith
    • 1
  • Susan E. Goebel
    • 2
  • Charles R. Culbert
    • 2
  • Louis A. Guilbault
    • 3
  1. 1.Ottawa Valley Veterinary Professional CorporationOttawaCanada
  2. 2.Food Safety DivisionBioniche Life Sciences, Inc.BellevilleCanada
  3. 3.BIOptima ConsultingSaint-BrunoCanada

Personalised recommendations